Cordycepin ameliorates lipopolysaccharide-challenged C2C12 myotube shrinkage by regulating sodium channel kinetics and inhibiting the protein degradation pathway
- DOI
- 10.1016/j.intimp.2026.117172
- Published
- 2026-10
- Container
- International Immunopharmacology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.intimp.2026.117172,
title = {Cordycepin ameliorates lipopolysaccharide-challenged C2C12 myotube shrinkage by regulating sodium channel kinetics and inhibiting the protein degradation pathway},
author = {Xiaoli Zhang and Chong Chen and Bin He and Zhenyu Zhang and Yuanjie Zhu and Shuyu Xi and Chunfang Cheng and Yuhua Li and Yanchun Gong and Kaizhi Ding and Lihua Yao},
year = {2026},
journal = {International Immunopharmacology},
doi = {10.1016/j.intimp.2026.117172},
url = {https://doi.org/10.1016/j.intimp.2026.117172}
}RIS
TY - JOUR TI - Cordycepin ameliorates lipopolysaccharide-challenged C2C12 myotube shrinkage by regulating sodium channel kinetics and inhibiting the protein degradation pathway AU - Xiaoli Zhang AU - Chong Chen AU - Bin He AU - Zhenyu Zhang AU - Yuanjie Zhu AU - Shuyu Xi AU - Chunfang Cheng AU - Yuhua Li AU - Yanchun Gong AU - Kaizhi Ding AU - Lihua Yao PY - 2026 JO - International Immunopharmacology DO - 10.1016/j.intimp.2026.117172 UR - https://doi.org/10.1016/j.intimp.2026.117172 ER -
APA
Zhang, X., Chen, C., He, B., Zhang, Z., Zhu, Y., Xi, S., Cheng, C., Li, Y., Gong, Y., Ding, K., & Yao, L. (2026). Cordycepin ameliorates lipopolysaccharide-challenged C2C12 myotube shrinkage by regulating sodium channel kinetics and inhibiting the protein degradation pathway. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2026.117172
Source records
- crossref · retrieved 2026-09-26T17:56:55.721Z